Ken has extensive experience across a range of therapeutic areas, including oncology and immuno-oncology, rare diseases, CNS research, auto-immune disease, cardiovascular, and endocrinology. He specializes in new product assessment/treatment landscape research and conducted numerous patient journey, demand research, and positioning/message testing studies.

Ken brings to his work a strong biomedical background that includes leading a developmental neuroscience lab at the Yale School of Medicine, numerous peer-reviewed publications based on his research of CNS development, and he served as the R&D Director at a biomed startup.

Ken has an M.S. from Bucknell University and a Ph.D. from Cornell University.